Managing Cyclic Vomiting and Cannabis Hyperemesis Attacks: What the Evidence Says About Home and ER Treatment
Abortive therapy cyclic vomiting syndrome is critical for managing CVS and CHS attacks effectively. Early intervention during the prodrome phase can reduce episode severity. This approach supports home and emergency department treatment strategies.
Mapping the Clinical Trial Landscape for Cannabinoids in Neurology: A Registry-Based Systematic Review
This systematic review of cannabinoid clinical trials neurological disorders highlights research focused on Multiple Sclerosis, Fibromyalgia, and Parkinson's Disease. It reveals challenges due to inconsistent protocols and dosing across studies. The…
Cannabis for Symptom Relief in HIV and Cancer: A Map of What We Know—and What We Don’t
Cannabis symptom management HIV cancer is an emerging field with limited but growing observational evidence. This review highlights gaps in dosing, safety, and effectiveness data. Patients and clinicians face uncertainty while seeking symptom relief…
Cannabis and Sleep: A Self-Reinforcing Cycle That May Worsen Both
The cannabis sleep bidirectional model explains how sleep problems lead to cannabis self-medication, which may worsen sleep issues through neurobiological effects. Over time, tolerance can develop, increasing the risk for cannabis use disorder. This…
Cannabinoids and Male Fertility: What Science Reveals
Cannabinoids male fertility interactions influence the male reproductive system in complex ways. Research shows cannabinoids affect erectile function and spermatogenesis, with THC posing risks. Understanding these effects is crucial for men concerned…
CBD Chewing Gum: Promising Concept, Thin Evidence
CBD chewing gum drug delivery is a promising concept with limited clinical evidence. Research gaps remain in absorption mechanisms, dosing precision, and long-term safety. Current trials show no significant efficacy over placebo.
Review of Cannabinoid Clinical Trials for Mental Health Treatment
This cannabinoid clinical trials mental health treatment review summarizes current evidence on cannabinoids' efficacy and safety for mental health disorders. The review highlights consistent adverse effects reported in trials. Careful clinical monitoring…
Why People Use Cannabis Predicts Whether Use Becomes Harmful, Review Finds
A 2024 narrative review highlights that cannabis use motives, particularly coping motives, strongly predict cannabis-related problems and disorder. Medical and coping motives overlap, complicating clinical assessment. Understanding cannabis use motives…
Can Cannabinoids Slow Ageing? Early Lab Evidence Is Intriguing, But Human Proof Remains Absent
Cannabinoids ageing preclinical evidence highlights CBD's role in autophagy induction and antioxidative system activation. Studies in nematodes show lifespan extension, but human data are lacking. This evidence is intriguing yet insufficient for clinical…
Cannabis Compounds Show Promise Against Cancer and Viral Disease—But the Evidence Is Still Largely Preclinical
This cannabis compounds medical evidence review summarizes recent research on cannabinoids in cancer and viral disease. While promising preclinical data exist, clinical evidence remains limited. The review clarifies where cannabis-derived therapies have…
